Programs - ILS2025 | Innovation Leaders Summit

1st Dec. 10:00 - 2nd Dec. 18:00

Toranomon Hills 5F Hall A1

Major Corporation Matching Booth

Major Company ・ CVC Matching Booth by Mori Building

5 large companies from the incubation center ARCH, which brings together new business divisions of large companies, and Startup HUB, which brings together CVCs and VCs, will be exhibiting booths for collaboration matching with startups. Don't miss out on meeting companies you wouldn't meet through power matching.

\ NOW ON STAGE /

Daiichi Sankyo Healthcare Co., Ltd.　(Open Innovation Team, Business Development Office)

Join Us in Shaping the Future of Healthcare

Daiichi Sankyo Healthcare Co., Ltd.　(Open Innovation Team, Business Development Office)

Join Us in Shaping the Future of Healthcare

Daiichi Sankyo Healthcare is dedicated to enhancing people's health and beauty by delivering OTC pharmaceuticals, functional skincare, oral care, and supplements to consumers through channels such as drugstores and e-commerce. By combining these assets with your unique technologies and services, we aim to co-create new value and business opportunities. We especially welcome innovators in the health tech, femtech, sleep tech sectors—come visit us at our booth!

Life Sciences / Drug Discovery / Medical Devices / Regenerative Medicine Digital Health / Well-being Food / Food Production / Agriculture / Fisheries

\ NOW ON STAGE /

ARIRGE CO., LTD.

Solving social issues related to cancer

ARIRGE CO., LTD.

Solving social issues related to cancer

In Japan, the retirement age is increasing as the working population decreases. As a result, the number of employees suffering from cancer is increasing, and the importance of information and support collaboration between industrial physicians and attending physicians is increasing. Arirju aims to solve social issues related to cancer and provides ""Arirju SUPPORT,"" Japan's first SaaS that connects companies and medical institutions. We are looking for partner companies that can work with us to create future work styles and solve social issues.

Digital Health / Well-being Life Sciences / Drug Discovery / Medical Devices / Regenerative Medicine

Close

1st Dec. 10:00 - 10:30

Toranomon Hills 5F Hall A1

Online: Channel2

Corporate Pitch

Lang: Japanese (Japanese-English simultaneous interpretation available)

Corporate Pitch -Startup companies we are seeking for right now-

Key people from major companies active in collaboration with start-ups take to the stage. This is an opportunity for each company to present their company's vision, areas of focus and needs for new business and new product development to start-ups, and to seek solution proposals from the start-ups. After each company's pitch, a simple exchange of business cards is possible.

\ NOW ON STAGE /

Daiichi Sankyo Healthcare Co., Ltd.　(Open Innovation Team, Business Development Office)

Creating the Future of Healthcare with Startups

Daiichi Sankyo Healthcare Co., Ltd.　(Open Innovation Team, Business Development Office)

Creating the Future of Healthcare with Startups

Daiichi Sankyo Healthcare deliver OTC pharmaceuticals, functional skincare, oral care, and supplements that contribute to health and beauty to consumers through channels such as drugstores and e-commerce. Together, let’s create exciting business and society that we alone could not achieve, aimed at realizing a "new era of healthcare" and improving people’s quality of life (QOL). With a spirit of openness and respect, we are ready to embark on new challenges with startups like you.

Life Sciences / Drug Discovery / Medical Devices / Regenerative Medicine Digital Health / Well-being Food / Food Production / Agriculture / Fisheries

\ NOW ON STAGE /

ARIRGE CO., LTD.

What future will Japan's first SaaS connecting companies and medical institutions pave the way for?

ARIRGE CO., LTD.

What future will Japan's first SaaS connecting companies and medical institutions pave the way for?

There are still many social issues related to cancer. One of these is employment for cancer patients. When it comes to supporting patients' employment, there is insufficient communication between industrial physicians and their primary physicians. Ariruge SUPPORT is Japan's first SaaS that builds an information sharing system between companies and medical institutions. By utilizing data, we aim to reduce patient anxiety and increase user convenience, contributing to ensuring that irreplaceable "ordinary" lives can continue "forever."

Digital Health / Well-being Life Sciences / Drug Discovery / Medical Devices / Regenerative Medicine

Close

2nd Dec. 10:00 - 2nd Dec. 18:00

Toranomon Hills 5F Hall A Foyer

Startup Booth

JFC Startup Booth

The Japan Finance Corporation (JFC) actively supports startups with innovative technologies and know-how. 10 startups aiming for high growth will be exhibiting booths with the support of JFC.

\ NOW ON STAGE /

Bionto, Inc

Development of transdermal DDS device using unique iontronics technology from Tohoku University

Bionto, Inc

Development of transdermal DDS device using unique iontronics technology from Tohoku University

Developing and providing innovative self-care and self-medication devices that use technology that enables the control and transmission of ions to create electro-osmotic flow that generates intradermal flow, allowing for the non-invasive administration of drugs and active ingredients through the skin.

Life Sciences / Drug Discovery / Medical Devices / Regenerative Medicine

Close

2nd Dec. 13:00 - 15:00

Toranomon Hills 5F Main Hall

Online: Channel1

Startup Pitches

Lang: Only Japanese (no simultaneous interpretation)

SMRJ Startup Pitch

SMRJ supports the growth of startups through acceleration program "FASTAR" and 29 incubation facilities. This time, 11 deep tech startups carefully selected by SMRJ will be pitching.

\ NOW ON STAGE /

Coatings that regenerate medical devices into bio-friendly ones

MPCoat® regenerates the coating surface to the same structure as the cell membrane to exhibit the inherent properties of living organisms. We will introduce basic characteristics of the product and seek applications for this product.

Coatings that regenerate medical devices into bio-friendly ones

MPCoat® regenerates the coating surface to the same structure as the cell membrane to exhibit the inherent properties of living organisms. We will introduce basic characteristics of the product and seek applications for this product.

Yoshihiro Kiritoshi│CEO & CTO, Intelligent Surfaces, Inc.

Life Sciences / Drug Discovery / Medical Devices / Regenerative Medicine

Close

3rd Dec. 10:00 - 4th Dec. 18:00

Toranomon Hills 5F Main Hall & Hall A1

Startup Booth

ILS Startup Booth [3-4 Dec]

Booth exhibits of the latest technologies and products by promising companies selected by the ILS Advisory Board of 117 organisations, comprising major domestic and international VCs, accelerators and support organisations
[Exhibit areas] Renewable energy / Decarbonization / SDGs / Smart grid / ICT / Next-generation communications / IoT / M2M / Education / Travel / Sports / Entertainment / Finance / Insurance / Virtual currency / Advertising / Marketing / Sharing economy / Retail / Food / Food production / Agriculture / Fisheries / Productivity improvement / Business process / Security / Real estate / Construction / Smart home / Smart city / Logistics / Supply chain / Others

\ NOW ON STAGE /

Cranebio Co., Ltd.

Making healthcare easier and more accessible

Cranebio Co., Ltd.

Making healthcare easier and more accessible

Medical tests that were previously only possible in hospitals/labs are now available as more affordable self-tests using unique technology and new ideas. Help solve the structural problems faced by modern medical institutions through the spread of preventive tests that anyone can easily perform at home.

Life Sciences / Drug Discovery / Medical Devices / Regenerative Medicine

\ NOW ON STAGE /

Milk.Inc

Next-generation image diagnosis system using space technology hyperspectrum

Milk.Inc

Next-generation image diagnosis system using space technology hyperspectrum

Hyperspectral technology was first installed on artificial satellites and has been used in vegetation analysis, mineral exploration, and military fields. We are developing the entire system, both hardware and software, to utilize this advanced spectroscopic technology and implement it in society.

Life Sciences / Drug Discovery / Medical Devices / Regenerative Medicine

\ NOW ON STAGE /

Nihon Science Innovation and Solutions Inc.

Fully human protein synthesis platform business

Nihon Science Innovation and Solutions Inc.

Fully human protein synthesis platform business

We synthesize fully human proteins in a short period of time and at low cost, and use them for everything from research reagents to GMP manufacturing. The pilot product has already been proven, and we are in the process of scaling it up while securing initial sales channels. This is the world's first patented technology.

Life Sciences / Drug Discovery / Medical Devices / Regenerative Medicine

\ NOW ON STAGE /

Solallisbio.Inc.

The world's first! Achieving safe regenerative medicine with a cell cryopreservation solution that does not contain organic solvents

Solallisbio.Inc.

The world's first! Achieving safe regenerative medicine with a cell cryopreservation solution that does not contain organic solvents

Cells can be stored for long periods of time by freezing, but this requires the use of toxic organic solvents. Our company has succeeded in developing the only preservation solution in the world that can solve this problem. Achieving regenerative medicine that eliminates the need for cleaning operations and reduces the burden on medical sites.

Life Sciences / Drug Discovery / Medical Devices / Regenerative Medicine

\ NOW ON STAGE /

AntiCancer Technologies Inc.

We make drugs for pancreatic cancer and small cell lung cancer.

AntiCancer Technologies Inc.

We make drugs for pancreatic cancer and small cell lung cancer.

We are working to develop inhibitors of three molecules involved in cancer cell proliferation and survival. Each target has the potential to become a new approach to refractory cancers and cancer types that are difficult to respond to existing treatments.

Life Sciences / Drug Discovery / Medical Devices / Regenerative Medicine

\ NOW ON STAGE /

Hokkaido University, Department of Cardiovascular Medicine, Heart Failure Team

Objective frailty determination system using AI analysis of walking videos of elderly heart failure patients

Hokkaido University, Department of Cardiovascular Medicine, Heart Failure Team

Objective frailty determination system using AI analysis of walking videos of elderly heart failure patients

We developed a smartphone app that uses AI to analyze walking videos of heart failure patients and objectively and automatically evaluates frailty, which used to be subjective and highly variable. The world's first medical device program that aims to improve the quality of medical care by supporting treatment policy decisions and rehabilitation interventions.

Life Sciences / Drug Discovery / Medical Devices / Regenerative Medicine

\ NOW ON STAGE /

EQUES, Co., Ltd.

Seamlessly connect the latest AI research and practice to implement better solutions in society

EQUES, Co., Ltd.

Seamlessly connect the latest AI research and practice to implement better solutions in society

We will make maximum use of AI, which is the latest technology in the world, and accelerate the current Japanese society. Based on commissioned development and joint research, we are engaged in the development and consulting of pharmaceutical AISaaS.

Life Sciences / Drug Discovery / Medical Devices / Regenerative Medicine

Close

3rd Dec. 10:00 - 10:41

Toranomon Hills 5F Hall A1

Online: Channel2

University and National Research Institute Pitch

Lang: Only Japanese (no simultaneous interpretation)

NEDO connect Dream Pitch [Day 1]

Six teams from universities and national research institutes, recommended by NEDO, will be showcasing their cutting-edge technology!
We look forward to welcoming everyone who is interested in collaboration and seed exploration in frontier fields such as energy-saving electronics, next-generation sensing, and AI systems.

\ NOW ON STAGE /

Continuous blood glucose measurement contact lens that can operate independently and generates electricity and measures from tear sugar

We are developing contact lenses for continuous blood sugar measurement. We are developing a low-power semiconductor integrated circuit with a configuration that can operate independently to generate and measure electricity from tear sugar.

Continuous blood glucose measurement contact lens that can operate independently and generates electricity and measures from tear sugar

We are developing contact lenses for continuous blood sugar measurement. We are developing a low-power semiconductor integrated circuit with a configuration that can operate independently to generate and measure electricity from tear sugar.

Kiichi Niitsu│Kyoto University, Niitsu Laboratory (Low-power integrated circuit design)

Life Sciences / Drug Discovery / Medical Devices / Regenerative Medicine

Close

3rd Dec. 10:00 - 4th Dec. 18:00

Toranomon Hills 5F Hall A1 & Hall A Foyer

Startup Booth

NEDO Exhibition with ITRI

Deep tech startups recommended by NEDO will be exhibiting! In addition, startups recommended by ITRI, Taiwan's largest industrial technology research and development organization, will also be exhibiting!

\ NOW ON STAGE /

KAICO Ltd.

A world expanding with proteins made from silkworms

KAICO Ltd.

A world expanding with proteins made from silkworms

For the purpose of developing pharmaceuticals, diagnostic agents, and reagents, we inject silkworms with an artificial ""baculovirus"" that efficiently produces proteins in the body to express recombinant proteins, which are then collected and purified to produce various target proteins.

Life Sciences / Drug Discovery / Medical Devices / Regenerative Medicine

\ NOW ON STAGE /

Egret・Lab, Co., Ltd.

Business using exosome purification technology that allows for high purity, high recovery rate, and mass purification

Egret・Lab, Co., Ltd.

Business using exosome purification technology that allows for high purity, high recovery rate, and mass purification

Exosomes are attracting attention in all industries, including drug discovery, diagnostics, cosmetics, and food. In particular, we conduct contract purification and sell purification tools for high purification, high recovery, and mass purification from culture fluids, etc.

Life Sciences / Drug Discovery / Medical Devices / Regenerative Medicine

\ NOW ON STAGE /

TearExo Inc.

Healthcare infrastructure business based on cancer risk testing tools using tear fluid

TearExo Inc.

Healthcare infrastructure business based on cancer risk testing tools using tear fluid

We will commercialize a cancer risk testing tool that uses tear fluid, provide it widely to people through hospitals, pharmacies, pharmaceutical companies, insurance companies, trading companies, etc., and collaborate with specialists to propose a healthcare infrastructure that promotes early detection and treatment of cancer.

Life Sciences / Drug Discovery / Medical Devices / Regenerative Medicine

\ NOW ON STAGE /

Shinbiosis Corporation

Nanopicobubble technology that will not disappear even after 10 years will change medicine and industry

Shinbiosis Corporation

Nanopicobubble technology that will not disappear even after 10 years will change medicine and industry

The patented NanoGAS®-FMT method innovatively improves the intestinal environment without using drugs. Based on the high level of safety obtained through specific clinical research, this next-generation technology is SDGs-compliant and has been expanded from medical care to food, drugs, and semiconductors, with industry-academia collaboration as its strength.

Life Sciences / Drug Discovery / Medical Devices / Regenerative Medicine

\ NOW ON STAGE /

iFlasco Co., Ltd.

High-performance research AI service that expands your thinking

iFlasco Co., Ltd.

High-performance research AI service that expands your thinking

The proprietary AI model ""AIFlasco"" platform is an AI model that imitates the thought process of professionals in various fields, and analyzes highly reliable information from all over the world from a variety of ""perspectives"" to support a wide range of new businesses, research and development, etc.

Life Sciences / Drug Discovery / Medical Devices / Regenerative Medicine

\ NOW ON STAGE /

S&K Biopharma Co., Ltd.

Pharmaceutical development of lactoferrin fusion protein formulation with improved blood stability

S&K Biopharma Co., Ltd.

Pharmaceutical development of lactoferrin fusion protein formulation with improved blood stability

We have successfully improved the lactoferrin found in breast milk, which can be administered safely to children, pregnant women, and the elderly.We have also discovered new functions such as inhibition of extracellular trap formation and neutralization of chondroitin sulfate E, and are developing therapeutic agents for diseases caused by these.

Life Sciences / Drug Discovery / Medical Devices / Regenerative Medicine

Close

3rd Dec. 10:00 - 4th Dec. 18:00

Toranomon Hills 5F Hall A Foyer

University and National Research Institute Booths

NEDO connect

NEDO-recommended university and national research laboratories, as well as startups, will exhibit their research and development results, aiming to create innovative new businesses!
Twelve teams will present cutting-edge seed technologies, such as electronics, next-generation sensing, AI systems, and nitrogen recovery, to new business and R&D personnel.

\ NOW ON STAGE /

Kyoto University, Niitsu Laboratory (Low Power Integrated Circuit Design)

Continuous blood glucose measurement contact lens that can operate independently and generates electricity and measures from tear sugar

Kyoto University, Niitsu Laboratory (Low Power Integrated Circuit Design)

Continuous blood glucose measurement contact lens that can operate independently and generates electricity and measures from tear sugar

We are developing contact lenses for continuous blood sugar measurement. We are developing a low-power semiconductor integrated circuit with a configuration that can operate independently to generate and measure electricity from tear sugar.

Life Sciences / Drug Discovery / Medical Devices / Regenerative Medicine

Close

3rd Dec. 10:42 - 13:17

Toranomon Hills 5F Hall A1

Online: Channel2

Startup Pitches

Lang: Only Japanese (no simultaneous interpretation)

NEDO Dream Pitch [Day 1]

Startups supported by NEDO's SBIR Promotion Program will make business pitches.
SBIR companies will take the stage to report on their achievements.

\ NOW ON STAGE /

From Medical Innovation to Industrial Game Changer — Nano Pico Bubble Technology

Nano Pico Bubble technology has been applied to next-generation fecal microbiota transplantation (FMT) in the medical field, achieving high efficacy and minimal invasiveness. 2024 clinical study in children with ASD was successfully completed. With bubbles that remain stable for over ten years, the technology demonstrates antimicrobial, antioxidant, and cleansing effects, meeting industrial needs to reduce drug use and promoting innovation across sectors.

From Medical Innovation to Industrial Game Changer — Nano Pico Bubble Technology

Nano Pico Bubble technology has been applied to next-generation fecal microbiota transplantation (FMT) in the medical field, achieving high efficacy and minimal invasiveness. 2024 clinical study in children with ASD was successfully completed. With bubbles that remain stable for over ten years, the technology demonstrates antimicrobial, antioxidant, and cleansing effects, meeting industrial needs to reduce drug use and promoting innovation across sectors.

MIKIKO TANAKA│CEO, Shinbiosis Corporation

Life Sciences / Drug Discovery / Medical Devices / Regenerative Medicine

Close

3rd Dec. 16:30 - 17:00

Toranomon Hills 5F Hall A1

Online: Channel2

Startup Pitches

Lang: Japanese or English (no simultaneous interpretation)

ILS Startup Pitch - Life Science / Drug Discovery / Medical devices / Regenerative medicine　Part 1 -

Promising startups recommended by 117 domestic and international organizations including VCs will showcase their latest technologies and products through pitches.

\ NOW ON STAGE /

Development of a Breakthrough Drug to Eliminate Incurable Cancers

Pancreatic and small cell lung cancers have five-year survival rates below 10%, and current drugs offer only months of extra life. We discovered a new drug that completely eliminated these deadly cancers in animal models. If successful, it could save countless lives and create a multi-billion-dollar market.

Development of a Breakthrough Drug to Eliminate Incurable Cancers

Pancreatic and small cell lung cancers have five-year survival rates below 10%, and current drugs offer only months of extra life. We discovered a new drug that completely eliminated these deadly cancers in animal models. If successful, it could save countless lives and create a multi-billion-dollar market.

Keiichi Nakayama│Chief Scientific Officer, AntiCancer Technologies Inc.

Life Sciences / Drug Discovery / Medical Devices / Regenerative Medicine

\ NOW ON STAGE /

AI-powered noninvasive glucose monitoring for painless, real-time care

We are motivated to free people with diabetes from pain and burden by creating a noninvasive, intelligent solution, aiming to transform chronic care into a sustainable, empowering experience.

AI-powered noninvasive glucose monitoring for painless, real-time care

We are motivated to free people with diabetes from pain and burden by creating a noninvasive, intelligent solution, aiming to transform chronic care into a sustainable, empowering experience.

Singular Wings Medical

Life Sciences / Drug Discovery / Medical Devices / Regenerative Medicine

\ NOW ON STAGE /

Real-Time Laser Insight into Change: The Next-Generation Analytical Platform

Molecular Insight’s ultrafast laser platform delivers real-time structural fingerprints of molecules in gases and liquids—without sample prep or fluorescence interference. Sub-0.1 s readouts and <10 µM sensitivity enable inline QC and closed-loop control for pharma, chemicals, and food

Real-Time Laser Insight into Change: The Next-Generation Analytical Platform

Molecular Insight’s ultrafast laser platform delivers real-time structural fingerprints of molecules in gases and liquids—without sample prep or fluorescence interference. Sub-0.1 s readouts and <10 µM sensitivity enable inline QC and closed-loop control for pharma, chemicals, and food

Kazuo Okemoto│Molecular Insight, CEO & Co-Founder

Life Sciences / Drug Discovery / Medical Devices / Regenerative Medicine

\ NOW ON STAGE /

Ultra-Compact Artificial Heart Transforming Right Heart Failure Treatment

Leveraging core technology from pediatric artificial heart research, we are developing an ultra-compact right ventricular assist device that enables life-saving support for right heart failure patients. With magnetic levitation innovation, it delivers unrivaled reliability and fuels global market growth.

Ultra-Compact Artificial Heart Transforming Right Heart Failure Treatment

Leveraging core technology from pediatric artificial heart research, we are developing an ultra-compact right ventricular assist device that enables life-saving support for right heart failure patients. With magnetic levitation innovation, it delivers unrivaled reliability and fuels global market growth.

Riku Egami│Ibaraki University, Venture Development Lead

Life Sciences / Drug Discovery / Medical Devices / Regenerative Medicine

\ NOW ON STAGE /

AI-based Smartphone Application for Automatic Frailty Assessment in Elderly Patients with Heart Failure

In elderly patients with heart failure, variability in frailty assessment due to subjective judgment has posed challenges in treatment selection. We have developed a smartphone application that enables AI to objectively and automatically assess frailty from a simple gait video. Using a patented walking course design, a physician-initiated clinical trial is currently underway. Following regulatory approval, we aim to verify clinical effectiveness and pursue reimbursement and commercialization.

AI-based Smartphone Application for Automatic Frailty Assessment in Elderly Patients with Heart Failure

In elderly patients with heart failure, variability in frailty assessment due to subjective judgment has posed challenges in treatment selection. We have developed a smartphone application that enables AI to objectively and automatically assess frailty from a simple gait video. Using a patented walking course design, a physician-initiated clinical trial is currently underway. Following regulatory approval, we aim to verify clinical effectiveness and pursue reimbursement and commercialization.

TOSHIYUKI NAGAI│Hokkaido University, Associate Professor (Clinical Professor), Hokkaido University

Life Sciences / Drug Discovery / Medical Devices / Regenerative Medicine

Close

3rd Dec. 17:10 - 17:40

Toranomon Hills 5F Hall A1

Online: Channel2

Startup Pitches

Lang: Japanese or English (no simultaneous interpretation)

ILS Startup Pitch - Life Science / Drug Discovery / Medical devices / Regenerative medicine　Part 2 -

Promising startups recommended by 117 domestic and international organizations including VCs will showcase their latest technologies and products through pitches.

\ NOW ON STAGE /

Selective Antibody Platform Targeting Cancer and Hepatic Stem Cells

NPB11 and NPB24 are first-in-class monoclonal antibodies that selectively target cancer and hepatic stem cells while sparing normal cells. This innovative platform enables precise cancer diagnosis, targeted therapy, and stem cell isolation, offering strong commercialization potential in oncology and regenerative medicine.

Selective Antibody Platform Targeting Cancer and Hepatic Stem Cells

NPB11 and NPB24 are first-in-class monoclonal antibodies that selectively target cancer and hepatic stem cells while sparing normal cells. This innovative platform enables precise cancer diagnosis, targeted therapy, and stem cell isolation, offering strong commercialization potential in oncology and regenerative medicine.

Dongho Choi│Founder & CEO, Research Institute of Regenerative Medicine and Stem Cells (RMSC)

Life Sciences / Drug Discovery / Medical Devices / Regenerative Medicine

\ NOW ON STAGE /

B2B test management platform for non-clinical CROs

CROTree is a B2B test management platform for non-clinical CROs. It enables efficient communication and integrated data management between sponsors and CROs, improving quality and transparency in outsourced studies.

B2B test management platform for non-clinical CROs

CROTree is a B2B test management platform for non-clinical CROs. It enables efficient communication and integrated data management between sponsors and CROs, improving quality and transparency in outsourced studies.

NaHyun Lee│Founder & CEO, Haon Biosolutions

Life Sciences / Drug Discovery / Medical Devices / Regenerative Medicine

\ NOW ON STAGE /

Revolutionizing Enzyme Production with PCM(Protein Crystal Material)

We enable the production and utilization of many high-value enzymes that have been difficult with conventional technologies. PCM/Protein Crystal Material, a breakthrough technology that encapsulates proteins in crystals, enabling cytotoxicity suppression, reactions with poorly soluble substrates, and cascade reactions with multiple enzymes.

Revolutionizing Enzyme Production with PCM(Protein Crystal Material)

We enable the production and utilization of many high-value enzymes that have been difficult with conventional technologies. PCM/Protein Crystal Material, a breakthrough technology that encapsulates proteins in crystals, enabling cytotoxicity suppression, reactions with poorly soluble substrates, and cascade reactions with multiple enzymes.

Yo Murofushi│Xtelligence Inc., CEO

Life Sciences / Drug Discovery / Medical Devices / Regenerative Medicine

\ NOW ON STAGE /

Innovative Technologies for Creating Regenerative Medicines

Drug screening in zebrafish faces challenges with permeability and off-target effects. Our Z-FIT has overcome these hurdles. Hits reproduce therapeutic effects in mammalian disease models and enable in vivo structural optimization. This strategy is based on an innovative platform with most efficient creation of novel regenerative medicines.

Innovative Technologies for Creating Regenerative Medicines

Drug screening in zebrafish faces challenges with permeability and off-target effects. Our Z-FIT has overcome these hurdles. Hits reproduce therapeutic effects in mammalian disease models and enable in vivo structural optimization. This strategy is based on an innovative platform with most efficient creation of novel regenerative medicines.

Hideki Ando│Sky Pharma, CEO

Life Sciences / Drug Discovery / Medical Devices / Regenerative Medicine

\ NOW ON STAGE /

An biopharmaceutical company developing breakthrough therapies

An innovative, commercial stage biopharmaceutical company based in China and focused on bringing transformative medicines for oncology, infectious and aging related diseases to patients in the world.

An biopharmaceutical company developing breakthrough therapies

An innovative, commercial stage biopharmaceutical company based in China and focused on bringing transformative medicines for oncology, infectious and aging related diseases to patients in the world.

Calvin Feng│Convalife Pharmaceuticals Co., Ltd., Financial Invesment manager

Life Sciences / Drug Discovery / Medical Devices / Regenerative Medicine

Close

4th Dec. 10:00 - 10:40

Toranomon Hills 5F Hall A2

Meetup

Big Trends Networking Sessions by Industry –Life sciences / Drug discovery / Medical devices / Regenerative medicine–

Life Sciences / Drug Discovery / Medical Devices / Regenerative Medicine

These are networking sessions for startups, major companies, VCs, and advisory board members participating in Power Matching to interact with each other by industry of interest. Two to three industries are held per day. Visitors can also participate.

\ NOW ON STAGE /

Exhibitor List

\ NOW ON STAGE /

NOF CORPORATION CORPORATE R&D DIV.

We ask for proposals on materials and technologies related to the field of "life/healthcare".

NOF CORPORATION CORPORATE R&D DIV.

We ask for proposals on materials and technologies related to the field of "life/healthcare".

NOF is a leading company in supply of materials for Drug Delivery system (DDS), pharmaceutical raw materials and biocompatible materials in life science field. In addition, we are focusing on developing materials for cell culture, purification, cryopreservation, etc. in the field of regenerative medicine. NOF is seeking for partners and new technologies in the field of regenerative medicine to develop our materials and to create a new business.

Close

4th Dec. 10:42 - 12:11

Toranomon Hills 5F Hall A1

Online: Channel2

Startup Pitches

Lang: Only Japanese (no simultaneous interpretation)

NEDO Dream Pitch [Day 2]

Startups supported by NEDO will be making business pitches. 17 companies from fields such as life sciences and biotechnology will be taking the stage.

\ NOW ON STAGE /

Revolutionizing the Global Vaccine System with Silkworm-Based Protein Technology

KAICO harnesses the power of silkworms to efficiently produce high-quality recombinant proteins using its proprietary silkworm–baculovirus expression system. Partnering with pharmaceutical companies, we are developing novel human and animal vaccines, including oral vaccines based on silkworm-derived antigens, aiming to transform global vaccine manufacturing and accessibility.

Revolutionizing the Global Vaccine System with Silkworm-Based Protein Technology

KAICO harnesses the power of silkworms to efficiently produce high-quality recombinant proteins using its proprietary silkworm–baculovirus expression system. Partnering with pharmaceutical companies, we are developing novel human and animal vaccines, including oral vaccines based on silkworm-derived antigens, aiming to transform global vaccine manufacturing and accessibility.

KUMAZAKI Yuki│CFO, KAICO Ltd.

Life Sciences / Drug Discovery / Medical Devices / Regenerative Medicine

\ NOW ON STAGE /

Development and commercialization of a home-use tonometer to prevent blindness

Launch of tonometer as a home medical device to prevent blindness due to glaucoma

Development and commercialization of a home-use tonometer to prevent blindness

Launch of tonometer as a home medical device to prevent blindness due to glaucoma

Hidenaga KOBASHI│CEO, Toneasy, Inc.

Life Sciences / Drug Discovery / Medical Devices / Regenerative Medicine

\ NOW ON STAGE /

Exosome Purification Technology Using the HAS Method and Its Applications

Based on our proprietary HAS method, which enables high-purity and high-recovery exosome purification, Egret・Lab is expanding its business from research support to regenerative medicine and drug discovery. We are developing large-scale purification packs and aim to collaborate with CDMO, cosmetics, and food companies in joint development and commercialization.

Exosome Purification Technology Using the HAS Method and Its Applications

Based on our proprietary HAS method, which enables high-purity and high-recovery exosome purification, Egret・Lab is expanding its business from research support to regenerative medicine and drug discovery. We are developing large-scale purification packs and aim to collaborate with CDMO, cosmetics, and food companies in joint development and commercialization.

Shinichi Yano│CEO, Egret・Lab, Co., Ltd.

Life Sciences / Drug Discovery / Medical Devices / Regenerative Medicine

\ NOW ON STAGE /

Development of lactoferrin fusion protein drugs with improved stability in the blood

We are developing a modified lactoferrin-based drug that enhances the natural effects of lactoferrin in breast milk to provide safe medicines for children, pregnant women, and the elderly. Proof-of-concept studies are underway for spinal cord injury, sepsis, and autoimmune hepatitis. After approval, we aim to expand indications and make it a first-line treatment for multiple diseases.

Development of lactoferrin fusion protein drugs with improved stability in the blood

We are developing a modified lactoferrin-based drug that enhances the natural effects of lactoferrin in breast milk to provide safe medicines for children, pregnant women, and the elderly. Proof-of-concept studies are underway for spinal cord injury, sepsis, and autoimmune hepatitis. After approval, we aim to expand indications and make it a first-line treatment for multiple diseases.

Shinji Kagaya│President & CEO, S&K Biopharma Co., Ltd.

Life Sciences / Drug Discovery / Medical Devices / Regenerative Medicine

\ NOW ON STAGE /

Empowering a Well-Being Society through tear-based liquid biopsy for breast cancer.

We provide a minimally invasive breast cancer detection method using tear fluid, which is easy and suitable for self-collecting. Tears can be collected anytime and anywhere, allowing simple screening not only in clinical or home settings but also in everyday locations such as pharmacies and salons. By using tear-based screening as a gateway to connect individuals with medical institutions, we aim to improve early detection rates and contribute to a well-being-oriented healthy society.

Empowering a Well-Being Society through tear-based liquid biopsy for breast cancer.

We provide a minimally invasive breast cancer detection method using tear fluid, which is easy and suitable for self-collecting. Tears can be collected anytime and anywhere, allowing simple screening not only in clinical or home settings but also in everyday locations such as pharmacies and salons. By using tear-based screening as a gateway to connect individuals with medical institutions, we aim to improve early detection rates and contribute to a well-being-oriented healthy society.

Ryo HORIKAWA│CEO, TearExo Inc.

Life Sciences / Drug Discovery / Medical Devices / Regenerative Medicine

Close

4th Dec. 17:00 - 17:40

Toranomon Hills 5F Hall A1

Online: Channel2

Seminar

Lang: Only Japanese (no simultaneous interpretation)

Co-creation mechanisms fostered through capital circulation and business collaboration

Life Sciences / Drug Discovery / Medical Devices / Regenerative Medicine

How can investors, business companies, and support organizations collaborate to foster a startup ecosystem in terms of both funding and business? We will discuss mechanisms for co-creation through efficient capital circulation.

\ NOW ON STAGE /

Mr. Yoshiaki Takai │ Dentsu Inc., Startup Growth Partners, Business Creation Division, Senior Business Producer / COO, NewsPicks Studios Inc.

After joining Dentsu, he gained experience in media, marketing, and business production. Following assignments in startups and the establishment of a specialized division, he now supports corporate value enhancement and ecosystem development for startups utilizing Dentsu’s assets, while also serving as COO of a joint venture.

\ NOW ON STAGE /

Moderator: Mr. Keigo Yato │ Beyond Next Ventures Inc., Capitalist

During his studies, he conducted research on immune responses to hepatitis vaccines and viruses at the National Institute of Infectious Diseases. Motivated by challenges in commercializing academic research seeds, he joined Beyond Next Ventures in April 2022 as a venture capitalist specializing in bio and drug discovery. Holds a Ph.D. in Engineering from Tokyo University of Science.

Close

ILS2025 Time Table